Subsequent functional enrichment analyses showed that these genes were enriched in lung disease, lung small cell cancer, the PI3K-Akt-mTOR pathway, and in epithelial-mesenchymal transition processes (Figure 4E). This evidence concerns the gene AKT1 and small cell lung carcinoma.